1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global H1N1 Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Breakup by Vaccines Type
5.5 Breakup by Market Type
5.6 Analysis of Key Brands
5.7 Breakup by Region
5.8 Market Forecast
6 Market Breakup by Vaccines Type
6.1 Intramuscular
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intranasal
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Intradermal
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Type
7.1 Public
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Private
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 Analysis of Key Brand
9.1 Agripal
9.2 Fiuarix
9.3 Influgen
9.4 Influvac
9.5 Nasovac
9.6 Vaxigrip
9.7 Others
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis
14 Industry Developments
14.1 Pipeline and New Product Launches
14.2 Mergers & Acquisitions and Partnerships
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AstraZeneca plc
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 CPL Biologicals Pvt. Ltd
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 CSL Limited
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Zoetis Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
List of Figures
Figure 1: Global: H1N1 Vaccines Market: Major Drivers and Challenges
Figure 2: Global: H1N1 Vaccines Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: H1N1 Vaccines Market: Breakup by Vaccines Type (in %), 2023
Figure 4: Global: H1N1 Vaccines Market: Breakup by Type (in %), 2023
Figure 5: Global: H1N1 Vaccines Market: Breakup by Region (in %), 2023
Figure 6: Global: H1N1 Vaccines Industry: SWOT Analysis
Figure 7: Global: H1N1 Vaccines Industry: Value Chain Analysis
Figure 8: Global: H1N1 Vaccines Industry: Porter’s Five Forces Analysis
Figure 9: Global: H1N1 Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: H1N1 Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: H1N1 Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: H1N1 Vaccines (Intranasal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: H1N1 Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: H1N1 Vaccines (Intradermal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: H1N1 Vaccines (Intradermal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: H1N1 Vaccines (Public) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: H1N1 Vaccines (Public) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: H1N1 Vaccines (Private) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: H1N1 Vaccines (Private) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: North America: H1N1 Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: North America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Europe: H1N1 Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Europe: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Asia Pacific: H1N1 Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Asia Pacific: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Middle East and Africa: H1N1 Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Middle East and Africa: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Latin America: H1N1 Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Latin America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
List of Tables
Table 1: Global: H1N1 Vaccines Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: H1N1 Vaccines Market Forecast: Breakup by Vaccines Type (in Million US$), 2024-2032
Table 3: Global: H1N1 Vaccines Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 4: Global: H1N1 Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: Global: H1N1 Vaccines Market Structure
Table 6: Global: H1N1 Vaccines Market: Key Players